Notice: Undefined index: User-Agent in /var/www/html/wp-config.php on line 121
R&D trends report | Rare disease diagnosis and treatments

Rare disease diagnosis and treatments: What academic projects and biotech assets are the R&D community reviewing?

This R&D trends report provides a data-led analysis of our Global Challenge campaign and online events that brought our partnering network together to surface new solutions to rare diseases. By focusing on industry engagement and geographical metrics, our team has worked to provide our academic, research commercialisation, and industry communities with a trustworthy resource on global university-industry collaboration and research trends in the rare diseases space.

Enter your details to access the white paper

This white paper includes:

  • The top rare disease innovations trending with industry 
  • Data insights around the research submitted by our global academic community
  • R&D priorities of industry leaders in the rare diseases space

Take a look inside

About the authors

Jake Mitchell

Jake is the IN-PART Digital Marketing Manager, having joined the team in April, 2021. He graduated from the University of Sheffield in 2018 after studying English Language and Linguistics. 

About IN-PART:

We believe that scientific collaborations should solve real-world problems and bring a positive impact to society. We facilitate and accelerate the bench-to-bedside journeys by connecting the right partners from industry and academia at the right time. Our intelligent matchmaking platform (Connect), and bespoke scouting tool (Discover) provide an opportunity for a global network of decision-makers to collaborate around novel innovations and expertise to establish meaningful partnerships.

IN-PART, a digital partnering platform for university-industry collaboration.

250+ universities and research institutes around the world currently showcase their research and innovation on IN-PART to find new collaboration partners in industry. R&D teams get free access to the platform (create an account here). There are no hidden costs and we don’t claim downstream success fees.

Discover, a bespoke scouting service for open innovation.

Through Discover, corporate R&D teams can leverage our extended academic network, which reaches multiple teams across 1,200+ universities and research institutes worldwide. In response to a specific research requirement or challenge, Discover enables R&D teams to identify new opportunities for commercialisation or to solicit proposals for new research

Interested in speaking with our Discover team? Request a demo |  TTO or academic? Sign-up for weekly Discover emails.